Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Allarity Therapeutics, Inc. (NASDAQ: ALLR)
ALLR Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-18.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
208.50%
ALLR Stock Analysis
ALLR
PE Ratio:
ALLR
PEG Ratio:
Not Available
ALLR
Forward EPS Growth (12 month):
0.00%
ALLR
PS Ratio:
74.2
ALLR
PSG Ratio:
Not Available
ALLR
Forward Revenue Growth (12 month):
0.00%
ALLR Articles
No data was found